Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$205.5M
+243.8% from 2023
Prescriptions
7,964
$25,798.66 per claim
Patients
1,896
1,516 prescribers
Total spending, 2024
$205.5M
$108,365.24 per patient
Medicare prescription drug plans paid $205.5M for Welireg in 2024, for 7,964 prescriptions and refills to 1,896 patients (up 243.8% from 2023). The average cost per claim was $25,798.66.
Texas had the highest Medicare cost for Welireg in 2024: $26.0M for 968 claims, followed by California ($16.1M).
Arnab Basu, hematology-oncology in Jacksonville, FL, had the highest Medicare cost for Welireg in 2024: 122 claims costing $3.1M.
Welireg is made by Merck & Co., Inc. (MRK), listed in the Medicare spending data as Merck Sharp & D.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Arnab Basu Jacksonville, FL | Hematology-Oncology | 122 | 20 | $3.1M |
| Hans J Hammers Dallas, TX | Medical Oncology | 69 | 11 | $1.9M |
| Zita D Lim Houston, TX |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 216 | 1,170 | 222 | $29.7M |
| 2023 | 380 | 2,289 | 451 | $59.8M |
| 2024 | 1,516 | 7,964 | 1,896 | $205.5M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Physician Assistant |
| 63 |
| 16 |
| $1.8M |
| Kathryn E Beckermann Franklin, TN | Hematology-Oncology | 56 | 11 | $1.4M |
| Nataliya Mar Orange, CA | Hematology-Oncology | 49 | Under 11 | $1.4M |
| Brian I Rini Nashville, TN | Hematology-Oncology | 47 | Under 11 | $1.3M |
| Rojer Ranjit Burlington, MA | Nurse Practitioner | 45 | Under 11 | $1.3M |
| Rosalie L Sicalag Houston, TX | Nurse Practitioner | 57 | Under 11 | $1.3M |
| Eric Jonasch Houston, TX | Medical Oncology | 44 | Under 11 | $1.2M |
| Michael E Hurwitz New Haven, CT | Medical Oncology | 46 | Under 11 | $1.1M |
| Jared D Knol Grand Rapids, MI | Hematology-Oncology | 45 | 11 | $1.1M |
| Margaret R Moorhead Charlotte, NC | Nurse Practitioner | 39 | Under 11 | $1.0M |
| Claud M Grigg Jr. Charlotte, NC | Hematology-Oncology | 35 | Under 11 | $982K |
| Moshe C Ornstein Cleveland, OH | Hematology-Oncology | 43 | 11 | $972K |
| Maura K Mahar Boston, MA | Nurse Practitioner | 33 | Under 11 | $968K |
| Ashley L Sumrall Charlotte, NC | Hematology-Oncology | 42 | Under 11 | $911K |
| James B Brugarolas Dallas, TX | Hematology-Oncology | 32 | Under 11 | $908K |
| Jessica P Cheng Houston, TX | Nurse Practitioner | 28 | Under 11 | $781K |
| Naomi S Balzer Philadelphia, PA | Internal Medicine | 27 | Under 11 | $779K |
| Elaine Lam Aurora, CO | Medical Oncology | 27 | Under 11 | $739K |
| Yasser Ged Baltimore, MD | Medical Oncology | 24 | Under 11 | $724K |
| Risa L Wong Pittsburgh, PA | Hematology-Oncology | 24 | Under 11 | $711K |
| Theodore S Gourdin Charleston, SC | Hematology-Oncology | 26 | Under 11 | $702K |
| Walter Stadler Zion, IL | Hematology-Oncology | 25 | Under 11 | $699K |
| Isaac A Bowman Gilbert, AZ | Hematology-Oncology | 26 | Under 11 | $698K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Merck Sharp & D MRK | 7,964 | $205.5M |